UCCELLI, Licia
 Distribuzione geografica
Continente #
NA - Nord America 17.730
AS - Asia 10.409
EU - Europa 6.483
SA - Sud America 1.739
Continente sconosciuto - Info sul continente non disponibili 444
AF - Africa 276
OC - Oceania 50
Totale 37.131
Nazione #
US - Stati Uniti d'America 17.184
SG - Singapore 3.847
CN - Cina 2.491
IT - Italia 1.859
BR - Brasile 1.362
VN - Vietnam 1.234
DE - Germania 837
HK - Hong Kong 804
UA - Ucraina 685
PL - Polonia 650
GB - Regno Unito 632
TR - Turchia 482
FI - Finlandia 409
SE - Svezia 323
BD - Bangladesh 316
FR - Francia 312
JP - Giappone 298
CA - Canada 267
IN - India 246
RU - Federazione Russa 214
MX - Messico 189
ID - Indonesia 152
AR - Argentina 117
ZA - Sudafrica 116
NL - Olanda 109
IQ - Iraq 83
BE - Belgio 75
ES - Italia 72
AT - Austria 56
CO - Colombia 55
EC - Ecuador 53
VE - Venezuela 53
PK - Pakistan 50
IR - Iran 46
LT - Lituania 46
AU - Australia 45
MY - Malesia 42
UZ - Uzbekistan 41
CL - Cile 36
SA - Arabia Saudita 33
CH - Svizzera 32
MA - Marocco 31
CZ - Repubblica Ceca 30
PH - Filippine 29
KR - Corea 27
TN - Tunisia 26
EG - Egitto 23
AE - Emirati Arabi Uniti 21
BG - Bulgaria 21
PY - Paraguay 20
TW - Taiwan 20
JM - Giamaica 19
JO - Giordania 19
BO - Bolivia 17
CR - Costa Rica 17
DK - Danimarca 17
HU - Ungheria 16
AZ - Azerbaigian 15
TH - Thailandia 15
IL - Israele 14
KE - Kenya 13
RO - Romania 13
DZ - Algeria 12
ET - Etiopia 12
KG - Kirghizistan 12
PT - Portogallo 12
NP - Nepal 11
UY - Uruguay 11
IE - Irlanda 10
LB - Libano 9
PE - Perù 9
KZ - Kazakistan 8
SY - Repubblica araba siriana 8
DO - Repubblica Dominicana 7
GT - Guatemala 7
HN - Honduras 7
LV - Lettonia 7
BY - Bielorussia 6
CY - Cipro 6
NI - Nicaragua 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
AO - Angola 5
EU - Europa 5
OM - Oman 5
RS - Serbia 5
AL - Albania 4
CG - Congo 4
GR - Grecia 4
GY - Guiana 4
HR - Croazia 4
MD - Moldavia 4
MK - Macedonia 4
NG - Nigeria 4
NO - Norvegia 4
PA - Panama 4
PS - Palestinian Territory 4
SN - Senegal 4
AM - Armenia 3
BN - Brunei Darussalam 3
Totale 36.622
Città #
Singapore 2.375
Ashburn 1.992
San Jose 1.426
Woodbridge 1.069
Fairfield 924
Chandler 805
Santa Clara 787
Hong Kong 782
Houston 778
Beijing 762
Jacksonville 725
Ann Arbor 686
Warsaw 632
Council Bluffs 542
Wilmington 382
Ho Chi Minh City 380
Ferrara 360
Los Angeles 360
New York 357
Dallas 354
Seattle 338
Tokyo 281
Hanoi 278
Cambridge 264
Nanjing 260
Izmir 257
The Dalles 241
Munich 220
Milan 195
Addison 194
Lauterbourg 182
Princeton 181
Helsinki 165
São Paulo 149
Boardman 128
Mexico City 113
Shanghai 113
Dearborn 100
Buffalo 95
Orem 92
Rome 92
San Diego 90
Turku 90
Bologna 86
Toronto 85
Jakarta 84
Dong Ket 81
London 80
Chicago 78
Shenyang 73
Brooklyn 72
Montreal 72
Johannesburg 70
Phoenix 68
Nanchang 67
Chennai 66
Tianjin 65
Denver 62
Frankfurt am Main 59
Bremen 58
Brussels 58
Da Nang 56
Redwood City 55
Hefei 54
Atlanta 53
Changsha 51
Stockholm 51
Boston 50
Hebei 48
Nuremberg 48
Haiphong 46
Poplar 46
Rio de Janeiro 42
Amsterdam 41
Moscow 40
San Francisco 38
Falls Church 36
Tashkent 35
Baghdad 34
Jiaxing 32
Ankara 31
Vienna 31
Jinan 30
Manchester 30
Kunming 27
Washington 27
Augusta 26
Brasília 26
Guangzhou 26
Belo Horizonte 25
Istanbul 25
Naples 25
Reggio Nell'emilia 25
San Mateo 25
Mountain View 24
Auburn Hills 23
Falkenstein 23
Biên Hòa 22
Curitiba 22
Mumbai 22
Totale 23.251
Nome #
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 530
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 398
Proactive Implementation of Quantitative Analysis of the Risk FMEA / FMECA in Nuclear Medicine Procedures 351
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 342
Biodistribution of nanostructured lipid carriers: a tomographic study 337
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 337
188Re(V) nitrido radiopharmaceuticals for radionuclide therapy 328
Sterilità e asepsi: metodologie, convalide e verifiche 314
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 308
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008-2018) (vol 24, 640, 2019) 294
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 292
A solvent-extraction module for cyclotron production of high-purity technetium-99m 284
E-learning as a tool to harmonize education and good quality assurance system in radiopharmacy 284
A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma 278
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 261
Brain perfusion SPET and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations 261
68 Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients 260
YAP-(S)PET small animal scanner: Quantitative results 256
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready? 253
Therapeutic Radiometals: Global Trends Analysis of Scientific Literature (2008 -2018) 248
An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)]:(-) efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid 245
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma 243
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 241
Convalida del processo in asepsi(test Media Fill): preparazioni ottenute a mezzo kit 241
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 238
Influence of Storage Temperature on Radiochemical Purity of 99mTc-Radiopharmaceuticals 236
A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [Tc-99m(N) (PXP)](2+) (PXP = diphosphine ligand) 233
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 232
Sampling considerations for high resolution small animal SPECT 228
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 227
Fractionation of radiopharmaceuticals: set-up and verification of an automatic system portable with integrated dose calibrator 226
A Study on the Gamma-Ray Background of the Images Obtained Using Accelerator- Produced 99mTc 225
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 224
Development of a β-spectrometer Based on TDCR Method for 99gTc Activity Estimations 221
A small animal hybrid PET-SPECT scanner: First in-vivo results. 220
Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons 220
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 218
Performance evaluation of the fully engineered YAP-(S)PET scanner for small animal imaging 216
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma 213
Co-ordination chemistry of S-methyl 2-methyldithiocarbazate and formation of [M≡N]2+(M = Tc or Re) species 212
First evaluation in humans of the new myocardial perfusion imaging agent 99mTcN-dbodc: safety, biodistribution and dosimetry assessment 212
Therapeutic radiometals: Worldwide scientific literature trend analysis (2008–2018) 212
Tc(IV)Cl4(PPh3)2 and Tc(III)Cl3(CH3CN)(PPh3)2 as precursors of trans dioxo technetium(V) complexes with chelating amines and tetraazamacrocycles 209
Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC 208
Labeling of Fatty Acid Ligands with the Strong Electrophilic Metal Fragment [99mTc(N)(PNP)]2+ (PNP=Diphosphane Ligand) 206
Extraction techniques of 99mTc from 100Mo Metal Target 206
Nitrido-technetium and -rhenium Complexes with Chelating Phosphines: Synthesis, Reactivity and Crystal Structures 205
Automated synthesis of 68Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations 202
Technetium-99m sestamibi leg scintigraphy for non-invasive assessment of propionyl-L-carnitine induced changes in skeletal muscle metabolism 200
Geometrically controlled selective formation of nitrido technetium(V) asymmetrical heterocomplexes with bidentate ligands 200
Technetium complexes with ligands of pharmacological interest 199
The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review 198
Erratum: A kit formulation for the preparation of 188Re- lipiodol: Preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma (Nuclear Medicine Communication (2004) 25 (691-699)) 198
A remotely controlled module for an in-hospital routine production of Tc-99m by medical cyclotrons 198
A Comparison of Separation and Purification Strategies for 51/52Mn cyclotron production 198
Design and synthesis of a redox-active Tc-99m radiopharmaceutical with ferrocenedithiocarboxylate [FcCS = Fe(C5H4CS2)(C5H5)-] 196
Development of a β-spectrometer for 99gTc Activity Estimations 196
Development of new 99mTc-labeled bisphosphonates for bone scintigraphy 195
Chemistry of the strong electrophilic metal fragment [99Tc(N)(PXP)]2+ (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules 194
Cyclotron-Production of 51/52Mn Isotopes: the METRICS Project Final Report 190
Comprehensive theoretical investigation of the accelerator-produced 99mTc: determination of post-EOB evolution of quality parameters 188
Imaging of the scrotum: beyond sonography 188
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 188
Interdisciplinary tasks in the cyclotron production of radiometals for medical applications. The case of 47Sc as example 188
A class of asymmetrical nitrido Tc-99m heterocomplexes as heart imaging agents with improved biological properties 188
188W/188Re generator system and its therapeutic applicacions 187
Underestimation of regional myocardial perfusion with Tc-99m sestamibi single-day rest/stress SPECT: a “drug washout” pitfall? 186
CYCLOTRON-BASED ALTERNATIVE PRODUCTION OF 99mTc: INFN RESEARCH ACTIVITIES 184
Dosimetry of 177Lu-PSMA-617 after mannitol infusion and glutamate tablet administration: Preliminary results of EUDRACT/RSO 2016-002732-32 IRST protocol 184
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 183
Radiochemical purity and stability of 99mTc-HMPAO preparations:the influence of pH, volume recovery, and storage conditions 182
Safety profile, biodistribution and dosimetry of the new myocardial perfusion imaging agent [99mTc]N.DBODC: first evaluation in Human. 180
Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake 180
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 179
Advances in radiopharmaceuticals for cardiac imaging: 99mTcN-NOET 179
Rolling in the Deep: Imaging Findings and Diagnostic Pearls in Gallstone Ileus 179
A picture of modern Tc-99m radiopharmaceuticals: Production, chemistry, and applications in molecular imaging 178
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications 177
The Role of [18F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary Approach 177
99Tc≡N/ 99mTc≡N-complexes with aminoacids, synthesis, and crystal structure of [ 99TcNCl (CYS-OEt) (PPh 3)] 177
Is There a Role for FAPI PET in Urological Cancers? 176
Asymmetrical nitrido Tc-99m heterocomplexes: A class of cardiac agents with unprecedented imaging properties. 176
Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties 176
Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals 175
Radiochemical purity and stability of 99mTc-HMPAO in routine preparations 175
Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy 173
Coordination chemistry of S-methyl,N-methyldithiocarbazate and formation of [M≡N]2+ (M = Tc, Re) species. 172
Rhenium(V) and Technetium(V) Nitrido Complexes with Mixed 2 Tridentate pigreco-Donor and Monodentate pigreco-Acceptor Ligands 172
Methodology and technical implementation of a procedure for automated production 68Ga-DOTATOC 172
Development and Evaluation of the Magnetic Properties of a New Manganese (II) Complex: A Potential MRI Contrast Agent 171
Cyclotron-Production of 51/52Mn Isotopes: An Update on the METRICS Project 171
MONTE CARLO SIMULATIONS IN RADIO-LIGAND THERAPY WITH LU-177 FOR NEUROENDOCRINE TUMOURS (NETS) 170
Evaluation of 99Mo and 99mTc Productions Based on a High-Performance Cyclotron 170
Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT 169
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 168
Validation of 99mTc and 177Lu quantification parameters for a Monte Carlo modelled gamma camera 167
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 166
Best Practices on Radiology Department Workflow: Tips from the Impact of the COVID-19 Lockdown on an Italian University Hospital 166
Worldwide ten-year trend analysis of the scientific literature on therapeutic radiometals (2008-2018) 165
Synthesis and characterization of nitrido Tc(V) and Re(V) complexes with ferrocenedithiocarboxylate {FcCS(2)=[Fe(C5H4CS2)(C5H5)](-)} 164
Totale 21.863
Categoria #
all - tutte 160.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.866
Totale 173.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.934 0 164 132 106 115 82 109 109 82 159 274 602
2022/20231.927 218 153 51 231 275 273 103 179 209 24 136 75
2023/20241.348 100 129 140 49 89 187 70 98 48 41 73 324
2024/20255.796 175 170 414 235 618 389 265 326 887 687 1.051 579
2025/202615.448 1.387 563 1.248 1.957 2.251 1.017 1.853 930 1.420 1.671 744 407
2026/20271.120 455 665 0 0 0 0 0 0 0 0 0 0
Totale 37.131